News & AnalysisNorthSea Therapeutics lands $80m Series CNorthSea Therapeutics B.V., a biotech company, has raised $80 million in Series C financing.ByIris Dorbian17 December 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs